To OTC Journal Members:
 

It's Finally Here For You: The New Site

In case you're wondering why the content has been a little sparse of late, you will find out on Monday when you check the OTC Journal's Web Site.

Over the nearly 11 years I have been publishing the OTC Journal, there have been lots of ups and downs and winners and losers in our little corner of the investing world- the MicroCap Space. It happened early on, so most of you probably don't remember. However, in the Winter of '99 I introduced readers to NetSol International on the BB at $3.50. The stock hit $75 on the NASDAQ about 15 months later at the top of the dot-com bubble. That was my biggest win of all time.

Since then there have been times when we had big winners in terms of price appreciation. In the last couple of years, Commerce Planet (CPNE), PhotoChannel (PNWIF), and Spicy Pickle (SPKL) all come to mind. These were all stocks you got an early look at, and if traded properly yielded doubles, triples, and quadruples. Followers know there have been plenty of losers as well.

However, I am still trying really hard to find you that $.50 to $5 stock that goes to $25 over a few years and sticks because the company is extraordinary. It's out there and I'll find it.

I also feel that over the years readers sometimes miss some of my key philosophies for successful microcap investing. I probably don't convey the concepts as well as I could. In today's Bear Market, my position on SSLs comes to mind as one you might not quite understand. These Suggested Stop Loss levels are all published for everyone to see, and they are designed to help you preserve equity dollars in tough markets and poor corporate performance. Every microcap I cover is currently trading below its SSL. If you didn't use them, it's probably because I did a poor job explaining the concept.

It all changes on Monday morning. Here's today's Big Announcement:

On Monday Morning, there will be a whole new and revamped version of the OTC Journal. I think you will like it. I have worked long and hard, and committed a fair amount of capital towards this day, but I believe it will be a far better publication than it has ever been.

The site is, and will be on an ongoing basis, very rich with Video Content. I have recorded 18 video clips, each running two to three minutes, for you to view. If you don't understand SSLs, Fibonacci Retracements, or reading the SEC filings, there is information on all these subjects. All you have to do is watch and use the tools.

The launch of the new site is timely, as we are going to move into a new era of ideas starting in September. I'll be focusing on larger, and profitable companies to start with as in a bear market we can find very attractive valuations. I'll also be moving outside the US, as companies are growing a lot faster in other regions of the world in certain sectors. You'll be getting a few ideas in the next big bubble: Alternative Energy.

Please check out the new site on Monday. Watch as many of the videos as you care to. I'll be adding more as time goes by.

Also, please send in your feedback. I'd love to hear if you like the new layout, the video content, and the design. Any suggestions on improved ways for navigating the site or any other subjects would be greatly appreciated.

Please email me at editor@otcjournal.com.

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com
 

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

(Insert specific company compensation here)

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.